Le Lézard
Classified in: Health, Business
Subject: SVY

Hospital CEOs are Preparing for Major Change in the Health Care Industry, According to Deloitte's Latest Research


BOSTON, Jan. 17, 2020  /PRNewswire/ -- For CEOs of large health care organizations, accelerating change has become the norm for the industry. However, making progress to accommodate these changes has been harder than expected, as seen in new research from the Deloitte Center for Health Solutions.

As used in this document, "Deloitte" means Deloitte LLP. Please see  www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. (PRNewsFoto/Deloitte)

The "Deloitte 2019 Health Care CEO Perspectives Study" includes interviews with 25 health system and six health plan CEOs about their changing responsibilities and the roles they will play in effecting change.

CEOs rated three top drivers of health care industry change within the next 10 years:

  1. Shift in care settings.
  2. Adoption of value-based payment models.
  3. Increase in the demands of proactive consumers.

"The industry change that CEOs are witnessing firsthand reflects our predictions of a more consumer-centered future of health," said Michael Main, managing director, Deloitte Consulting LLP. "Consumers want to take control of their health ? they have been responding well to virtual care visits and are interested in tools that make their experience personalized, affordable and convenient."

Due to slow progress adopting value-based care however, CEOs are shifting their focus and investments toward consumer engagement technologies, virtual health and care coordination models. CEOs that do so may put their organizations in a good place if and when reimbursements eventually change to value-based payment models, increasing competitive advantage and consumer loyalty.

Some of the most innovative CEOs are heavily invested in making the customer's health care experience seamless and personalized so it's convenient to access, lower in price and convenient through multiple access points ? digital, personal and otherwise. They particularly want to engage and compete with those in the younger generation who are seeking alternative channels and sources for care and health. CEOs realize they have a lot of work to do in this area, as many health systems have yet to successfully complete digital transformations.

In addition to these key changes, CEOs are preparing to address disruption from competitors. Although many see the large retail consumer technology companies as only minor threats, many CEOs are still working to better position themselves to combat the risk of disruption. One way they are doing so is by reshaping their existing talent. They are retaining and training their current staff to better prepare them for the future. Others are looking externally to outside industries to bring in new ideas.

One thing all CEOs collectively agreed on is the need to expand and deepen partnerships. Working with the whole ecosystem ? payers, providers, schools, public health organizations and community organizations ? can help them expand reach and gain influence.

To review the full findings of the 2019 Health Care CEO Perspectives Study, please visit Deloitte Insights.

The source for fresh perspectives in health care: The Deloitte Center for Health Solutions (DCHS), part of Deloitte LLP's life sciences and health care practice, looks deeper at the biggest industry issues and provides new thinking around complex challenges. Cutting-edge research and thought-provoking analysis give our clients the insights they need to see things differently and address the changing landscape.

To learn more about the DCHS and our research, please visit www.deloitte.com/centerforhealthsolutions.

About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including nearly 90% of the Fortune 500® and more than 5,000 private and middle market companies. Our people work across the industry sectors that drive and shape today's marketplace ? delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Now celebrating 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte's more than 312,000 people worldwide make an impact that matters at www.deloitte.com.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

SOURCE Deloitte


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: